About Verismo Therapeutics
Verismo Therapeutics is a private company based in Philadelphia, Pennsylvania. It has reported $63,150,012 raised in three offerings on Form D since April 2021. Its chief executive is Bryan Kim.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | May 20, 2026 | $28,000,000fully sold | 1 | $28.0M | EquityRule 506(b) | Form D ↗ |
| Jul 7, 2023 | Jul 14, 2023 | $19,150,012target not set | 7 | $2.7M | EquityRule 506(b) | Form D ↗ |
| Apr 26, 2021 | Apr 27, 2021 | $16,000,000fully sold | 3 | $5.3M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $63,150,012 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Verismo Therapeutics's Form D filed May 20, 2026.
Earlier filings also listed Hyuk Jee (director, last listed Jul 2023).